Effects of a drug that blocks the vascular beta 2-receptors on blood prostanoid levels during physical exercise.
D015121:6-Ketoprostaglandin F1 alpha / Q000097:blood; D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D015232:Dinoprostone; D005080:Exercise Test; D005260:Female; D006801:Humans; D007192:Indenes / Q000494:pharmacology*; D008297:Male; D005082:Physical Exertion / Q000187:drug effects*; D011412:Propanolamines / Q000494:pharmacology*; D011453:Prostaglandins / Q000097:blood*; D011458:Prostaglandins E / Q000097:blood; D011459:Prostaglandins E, Synthetic / Q000097:blood; D013929:Thromboxane B2 / Q000097:blood
D000319:Adrenergic beta-Antagonists; D007192:Indenes; D011412:Propanolamines; D011453:Prostaglandins; D011458:Prostaglandins E; D011459:Prostaglandins E, Synthetic; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; C002989:indenolol; D015232:Dinoprostone